Skip to content
Application 214102
- Type
- ANDA
- Sponsor
- NOVITIUM PHARMA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | VALSARTAN | VALSARTAN | SOLUTION;ORAL | 20MG/5ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 70954-310 | Valsartan | Valsartan | Novitium Pharma LLC | ANDA | Current |
| 72336-910 | Valsartan | Valsartan | Lifsa Drugs LLC | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 69691 | ORIG | 2021-12-20 |